Search

Search Constraints

You searched for: Author/Creator Venugopal, Balaji

Search Results

2. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Issue 9 (September 2022)

3. Cardiotoxicity and myocardial hypoperfusion associated with anti‐vascular endothelial growth factor therapies: prospective cardiac magnetic resonance imaging in patients with cancer. (7th May 2020)

4. Real‐world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer. (15th October 2017)